PHARMACOKINETIC COMPARISON BETWEEN FIXED DOSE COMBINATION OF FIMASARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE 60/10/25 MG AND CORRESPONDING LOOSE COMBINATION.

被引：0
|
作者：
Lee, S. [1 ]
Lee, S. [1 ]
Yoo, H. [1 ]
Jeon, I. [1 ]
Na, J. [1 ]
Jang, I. [1 ]
Yu, K. [1 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
E-007
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [21] Clinical Impact of Patient Adherence to a Fixed-Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide
    Peter Bramlage
    Reinhard Ketelhut
    Eva-Maria Fronk
    Wolf-Peter Wolf
    Rüdiger Smolnik
    Claudia Zemmrich
    Roland E. Schmieder
    Clinical Drug Investigation, 2014, 34 : 403 - 411
  • [22] Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2018, 34 (1) : 1 - 7
  • [23] Efficacy and safety of a fixed-dose combination of telmisartan 80 mg and hydrochlorothiazide 25 mg in patients with uncontrolled hypertension
    Neldam, S.
    Edwards, C.
    JOURNAL OF HYPERTENSION, 2007, 25 : S114 - S114
  • [24] Correction to: Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2018, 34 (7) : 350 - 350
  • [25] Olmesartan medoxomil/amlodipine/hydrochlorothiazide fixed-dose combination: a guide to its use in hypertension
    Drugs & Therapy Perspectives, 2011, 27 (11) : 6 - 9
  • [26] Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice
    Bramlage, Peter
    Zemmrich, Claudia
    Ketelhut, Reinhard
    Wolf, Wolf-Peter
    Fronk, Eva-Maria
    Schmieder, Roland E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 475 - 483
  • [27] Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
    Kang, Woo Youl
    Seong, Sook Jin
    Ohk, Boram
    Gwon, Mi-Ri
    Kim, Bo Kyung
    Cho, Seungil
    Shim, Wang-Seob
    Lee, Kyung-Tae
    Kim, Eun Hee
    Yang, Dong Heon
    Lee, Hae Won
    Yoon, Young-Ran
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3607 - 3615
  • [28] Effect of Food on the Oral Bioavailability of Amlodipine/Valsartan and Amlodipine/Valsartan/Hydrochlorothiazide Fixed Dose Combination Tablets in Healthy Subjects
    Sunkara, Gangadhar
    Jiang, Xuemin
    Reynolds, Christine
    Serra, Denise
    Zhang, Yiming
    Ligueros-Saylan, Monica
    Ayalasomayajula, Surya
    Winter, Serge
    Jarugula, Venkateswar
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 487 - 492
  • [29] EFFICACY AND TOLERABILITY OF A FIXED COMBINATION OF METOPROLOL CR ZOK 100 MG AND HYDROCHLOROTHIAZIDE (HCT) 12.5 MG IN COMPARISON WITH THE FIXED COMBINATION OF METOPROLOL AND HCT
    LEIKERSFELDT, G
    RASMUSSEN, SL
    ATMER, B
    HJALMERS, S
    WAHLQVIST, I
    JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02): : S78 - S81
  • [30] BIOEQUIVALENCE STUDY OF A FIXED DOSE COMBINATION OF IRBESARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE FILM COATED TABLET MANUFACTURED IN TURKEY
    Uslu, Abdullah
    Dikmen, Ilksen
    Kokturk, Mustafa
    Unlu, Serdar
    Unsalan, Seda
    Cakici, Iclal
    Eren, Sami
    Kilinc, Berrak
    Saglam, Onursal
    Nacak, Muradiye
    Ocak, Omer
    NOBEL MEDICUS, 2014, 10 (03): : 24 - 31
12345